Dysbiosis-induced IL-33 contributes to impaired antiviral immunity in the genital mucosa

Proc Natl Acad Sci U S A. 2016 Feb 9;113(6):E762-71. doi: 10.1073/pnas.1518589113. Epub 2016 Jan 25.

Abstract

Commensal microbiota are well known to play an important role in antiviral immunity by providing immune inductive signals; however, the consequence of dysbiosis on antiviral immunity remains unclear. We demonstrate that dysbiosis caused by oral antibiotic treatment directly impairs antiviral immunity following viral infection of the vaginal mucosa. Antibiotic-treated mice succumbed to mucosal herpes simplex virus type 2 infection more rapidly than water-fed mice, and also showed delayed viral clearance at the site of infection. However, innate immune responses, including type I IFN and proinflammatory cytokine production at infection sites, as well as induction of virus-specific CD4 and CD8 T-cell responses in draining lymph nodes, were not impaired in antibiotic-treated mice. By screening the factors controlling antiviral immunity, we found that IL-33, an alarmin released in response to tissue damage, was secreted from vaginal epithelium after the depletion of commensal microbiota. This cytokine suppresses local antiviral immunity by blocking the migration of effector T cells to the vaginal tissue, thereby inhibiting the production of IFN-γ, a critical cytokine for antiviral defense, at local infection sites. These findings provide insight into the mechanisms of homeostasis maintained by commensal bacteria, and reveal a deleterious consequence of dysbiosis in antiviral immune defense.

Keywords: IL-33; commensal microbiota; dysbiosis; genital tract; herpes simplex virus type 2.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Antiviral Agents / immunology*
  • Colony Count, Microbial
  • Dysbiosis / complications*
  • Eosinophils / drug effects
  • Eosinophils / metabolism
  • Female
  • Herpes Genitalis / immunology
  • Herpes Genitalis / pathology
  • Herpes Genitalis / virology
  • Herpesvirus 2, Human / drug effects
  • Immunity, Innate* / drug effects
  • Interferon-gamma / biosynthesis
  • Interleukin-33 / metabolism*
  • Mice, Inbred C57BL
  • Microbiota / drug effects
  • Mucous Membrane / immunology
  • Mucous Membrane / pathology*
  • Mucous Membrane / virology
  • Peptide Hydrolases / metabolism
  • T-Lymphocytes / drug effects
  • Vagina / drug effects
  • Vagina / immunology*
  • Vagina / pathology
  • Vagina / virology

Substances

  • Anti-Bacterial Agents
  • Antiviral Agents
  • Interleukin-33
  • Interferon-gamma
  • Peptide Hydrolases